- Abstract submission must be in one of three different categories:
a. Medical or Research Professional / Clinician
b. Allied Health Professional / Practice and Research
c. PARE Member / Patient
The categories are subdivided into topics (Abstract topics >>).
The correct category and topic must be selected to ensure correct scoring. The content of the abstract must be topic related.
- Please carefully read all instructions in the abstract submission system before preparing your abstract.
-
For standardisation, the acceptable length of the abstract is
not more than 3600 printable characters and 42 lines,
author's details and headers included. This also includes nonvisible
characters such as spaces and punctuation.
- The abstract should be structured into the following sections:
a. Title which clearly indicates the nature of the investigation
b. Background
c. Objectives
d. Methods
e. Results
f. Conclusions
g. References
- One graph/image can be included with the following criteria:
Max image width: 500 pixels
Max image height: 500 pixels
Max file size: 500 KB
Allowed file type: gif, jpg
Please note that insertion of graphs and images may significantly reduce the number of remaining allowed characters.
-
If your submitted abstract has been accepted by the system, you will receive a confirmation number. If no confirmation number is received, the abstract cannot be considered as successfully submitted.
-
Submitted abstracts can be re-edited and modified until the submission deadline. Therefore, the submitting author will be required to create an
user account during submission. To submit the abstract all required fields must be filled in. If you leave the system without having saved the abstract all data is lost. Submitted abstracts cannot be edited after the
submission deadline (31 January 2010, Midnight CET).
- An abstract can only be submitted if the "Ethical Declaration" on the online abstract form is accepted by entering the submitting author's initials.
-
Disclosure of Interest. It is the intend of EULAR to provide high-quality sessions focused on educational content that is free from commercial
influence or bias. Thus, the submitting author of an abstract is requested to declare any potential conflicts of interest for all authors during the abstracts submission.
-
Abstracts accepted for the congress are subject to the "Abstract Embargo Rules" and the "Transfer of Copyright" (more information in the right column).
-
The Corresponding Author has the right to grant, and does grant, on
behalf of all authors an exclusive licence on a worldwide basis to the BMJ Publishing Group Ltd and EULAR, to publish the abstract (if accepted) in any media and to exploit all subsidiary rights.
- An abstract should not be submitted if it has been identically presented on a previous occasion.
-
The reviewers will judge the abstracts according to the scientific or clinical value, relevance to EULAR, suitability of methods to aims, conclusions confirmed by objective results, objectivity of statements, description of methods used, ethics, originality of work, standard of English and overall impression.
-
Please ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be reproduced exactly as submitted. No proofreading will be done.
-
Accepted abstracts will be published either in the congress abstract book, a supplement to "The Annals of the Rheumatic Diseases - The EULAR Journal", or on USB keys which will be distributed to participants together with the congress bags. Accepted abstracts will also be available on-line on this web site, about one month prior to the congress and thereafter in the EULAR Abstracts archives on this web site.
-
The submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) orally or as a poster in the session and at the time assigned by the EULAR Scientific Committee. We therefore recommend that submitters of abstracts register for the congress simultaneously with abstract submission.
-
Abstracts not adhering to these guidelines will be rejected. If you do not agree with any of these rules, you should not submit an abstract. The final decision about acceptance of an abstract will be taken by the EULAR Scientific Committee. EULAR does not correspond on the acceptance/rejection of an abstract.
-
If you need to withdraw your abstract, a written statement reflecting the reasons for this decision must be sent to the EULAR Secretariat or MCI not later than 10 April 2010.